AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $665,496 | +79.4% | 23,700 | +109.7% | 0.01% | +100.0% |
| Q4 2021 | $371,000 | -69.4% | 11,300 | -48.7% | 0.00% | -76.9% |
| Q2 2021 | $1,214,000 | -15.2% | 22,035 | -20.6% | 0.01% | -23.5% |
| Q1 2021 | $1,432,000 | +82.4% | 27,736 | +23.7% | 0.02% | +13.3% |
| Q3 2020 | $785,000 | +15.8% | 22,428 | +77.0% | 0.02% | +66.7% |
| Q2 2020 | $678,000 | +196.1% | 12,668 | +95.9% | 0.01% | -35.7% |
| Q1 2020 | $229,000 | -60.6% | 6,468 | -41.2% | 0.01% | -85.9% |
| Q3 2016 | $581,000 | +82.7% | 11,000 | +40.3% | 0.10% | -23.8% |
| Q1 2016 | $318,000 | – | 7,841 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |